Valuation : Formycon AG

Market Cap 364M 423M 345M 312M 586M 40.37B 589M 4.09B 1.57B 20.54B 1.59B 1.55B 64.9B P/E 2026 *
687x
P/E 2027 * 15.5x
Enterprise Value 478M 555M 453M 410M 770M 53.03B 774M 5.38B 2.07B 26.98B 2.08B 2.04B 85.25B EV / Sales 2026 *
6.58x
EV / Sales 2027 * 4.25x
Free-Float
70%
Yield 2026 *
-
Yield 2027 * -
1 week+0.49%
Current month+7.07%
1 month+11.35%
3 months+0.24%
6 months+6.85%
Current year-19.53%
1 week 20
Extreme 20
20.75
1 month 18.02
Extreme 18.02
20.9
Current year 15.8
Extreme 15.8
26.95
1 year 15.8
Extreme 15.8
26.95
3 years 15.8
Extreme 15.8
67.8
5 years 15.8
Extreme 15.8
94.1
10 years 14.65
Extreme 14.65
94.1
Manager TitleAgeSince
Chief Executive Officer - 30/06/2022
Director of Finance/CFO 57 31/03/2023
Chief Tech/Sci/R&D Officer - 30/06/2022
Director TitleAgeSince
Director/Board Member 49 09/12/2020
Chairman 54 11/06/2024
Director/Board Member 54 11/06/2024
Date Insider Type Main position Quantity % Market Cap. Importance
21/02/25 Buy

Chief Technology Officer

160 0.0009%
29/04/24 Buy

Executive/Senior Manager

1,200 0.0068%
24/04/24 Buy

Chief Executive Officer

2,500 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.49%-7.21%-65.03% 423M
-0.71%-6.35%-2.99%+9.59% 45.48B
+0.21%-2.98%+337.74%+519.55% 43.68B
+1.74%-2.24%+39.82%+20.76% 43.09B
+1.38%-3.28%+6.84%+67.62% 39.4B
-1.44%-5.26%+8.97%+39.76% 31.91B
+0.87%-2.60% - - 17.31B
+0.75%-0.64%+19.75%+110.17% 16.4B
-0.31%-2.78%+10.78%+31.02% 14.24B
+1.93%-3.55%+82.00%+41.17% 13.28B
Average +0.44%-3.17%+55.08%+86.07% 26.52B
Weighted average by Cap. +0.41%-3.66%+74.43%+123.94%

Financials

2026 *2027 *
Net sales 72.66M 84.33M 68.8M 62.36M 117M 8.06B 118M 817M 314M 4.1B 317M 310M 12.95B 112M 130M 106M 96.45M 181M 12.46B 182M 1.26B 486M 6.34B 490M 479M 20.03B
Net income 343K 398K 325K 294K 552K 38.03M 555K 3.86M 1.48M 19.35M 1.5M 1.46M 61.14M 23.19M 26.92M 21.96M 19.9M 37.34M 2.57B 37.53M 261M 100M 1.31B 101M 98.87M 4.13B
Net Debt 114M 133M 108M 98.01M 184M 12.66B 185M 1.28B 494M 6.44B 498M 487M 20.36B 113M 132M 107M 97.32M 183M 12.57B 184M 1.28B 490M 6.4B 494M 483M 20.21B
Logo Formycon AG
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
Employees
196
Date Price Change Volume
11/09/26 €20.60 0.00% 1,583
10/09/26 €20.60 +1.48% 5,479
09/09/26 €20.30 -1.46% 2,932
08/09/26 €20.60 +0.73% 11,435
07/09/26 €20.45 -0.24% 3,852
Trader
Investor
-
Global
-
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
20.60EUR
Average target price
39.67EUR
Spread / Average Target
+92.56%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!